Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literatur...

Por Haj Mohammad, N., ter Veer, E., Ngai, L., Mali, R., van Oijen, M. G. H., van Laarhoven, H. W. M.
Publicado no Cancer Metastasis Rev (2015)

Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands

Por Haj Mohammad, N., Bernards, N., Besselink, M. G. H., Busch, O. R., Wilmink, J. W., Creemers, G. J. M., De Hingh, I. H. J. T., Lemmens, V. E. P. P., van Laarhoven, H. W. M.
Publicado no J Cancer Res Clin Oncol (2016)

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent

Por Haj Mohammad, N., Walter, A. W., van Oijen, M. G. H., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Anderegg, M. C. J., van Berge Henegouwen, M. I., Henselmans, I., Sprangers, M. A. G., van Laarhoven, H. W. M.
Publicado no Support Care Cancer (2015)